Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Sufentanil Sublingual Microtablet in Healthy Subjects
NCT02082236Phase 1Completed
- Sponsor
- Talphera
- Start
- May 2014
- Primary completion
- May 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of sufentanil in pain (4 arms), sponsored by Talphera. Primary endpoint: Area Under the Curve at 9 days. Started May 2014; status: completed.
02
Drugs
sufentanil
03
Conditions
pain
Beyond the preview
Go deeper on NCT02082236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02082236.